Paper · 7908796
Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI and 2 others. Arch Surg, 1994. Cited by 116 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation. Papers, record 7908796. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7908796
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ampulla of Vater | Major topic |
| Common Bile Duct Neoplasms | Major topic |
| Pancreaticoduodenectomy | Major topic |
| Adenocarcinoma | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Bile Duct Neoplasms | |
| Body Weight | |
| Carcinoma | |
| Diabetes Mellitus, Type 1 | |
| Duodenal Neoplasms | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Pancreatectomy | |
| Pancreatic Ducts | |
| Pancreatic Neoplasms | |
| Pylorus | |
| Retrospective Studies | |
| Survival Rate |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,371,362 | Technical and clinical success rates of WallFlex duodenal stents in unresectable malignant gastric outlet obstruction. A retrospective observational study from a tertiary cancer hospital in India. | Prz Gastroenterol | 2022 | https://conductscience.org/library/papers/35371362 | PubMed |
| 33,005,656 | Readmissions after Pancreatic Surgery in Patients with Pancreatic Cancer: Does Hospital Variation Exist for Quality Measurement? | Visc Med | 2020 | https://conductscience.org/library/papers/33005656 | PubMed |
| 30,483,731 | Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/30483731 | PubMed |
| 28,396,720 | Delayed gastric emptying following pancreaticoduodenectomy: Incidence, risk factors, and healthcare utilization. | World J Gastrointest Surg | 2017 | https://conductscience.org/library/papers/28396720 | PubMed |
| 28,012,325 | Short- and long-term outcomes after pancreaticoduodenectomy following total gastorectomy: Report of case series and literature review. | Int J Surg Case Rep | 2017 | https://conductscience.org/library/papers/28012325 | PubMed |
| 23,869,542 | Factors associated with delayed gastric emptying after pancreaticoduodenectomy. | HPB (Oxford) | 2013 | https://conductscience.org/library/papers/23869542 | PubMed |
| 23,338,795 | Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer. | Drugs Aging | 2013 | https://conductscience.org/library/papers/23338795 | PubMed |
| 20,635,086 | Pancreaticojejunal bridge-anastomosis: a novel option for surgeon to preserve pancreatic body and tail in urgent reoperation for intra-abdominal massive hemorrhage after pancreaticoduodenectomy. | World J Surg | 2010 | https://conductscience.org/library/papers/20635086 | PubMed |
| 20,446,118 | A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators. | J Gastrointest Surg | 2010 | https://conductscience.org/library/papers/20446118 | PubMed |
| 20,020,091 | [Survival, mortality and quality of life after pylorus-preserving or classical Whipple operation. A systematic review with meta-analysis]. | Chirurg | 2010 | https://conductscience.org/library/papers/20020091 | PubMed |
1 to 10 of 26
See all 26 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7908796
GET https://conductscience.org/api/papers/v1/7908796/cited_by?page=2